Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Sparve

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Drug Testing and Analysis|October 19, 2017
A simple validated multi-analyte method for detecting drugs in oral fluid by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS)Yufang Zheng, Erik Sparve, Mats Bergström
Journal of Analytical Toxicology|March 5, 2020
Detection of Drugs in Oral Fluid Samples Using a Commercially Available Collection Device: Agreement with Urine Testing and Evaluation of A and B Samples Obtained from Employees at Different Workplace Settings with Uncontrolled Sampling ProceduresYufang Zheng, Erik Sparve, Stefan Sparring, et al.
Journal of Clinical Psychopharmacology|May 15, 2009
Acute clozapine intoxicationErik Sparve, Per Nordberg, Sune Forsberg, et al.
Basic & Clinical Pharmacology & Toxicology|August 19, 2009
Human exposure to triclosan via toothpaste does not change CYP3A4 activity or plasma concentrations of thyroid hormonesMats Allmyr, Georgios Panagiotidis, Erik Sparve, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2021
A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout FlaresKenneth G Saag, Puja P Khanna, Robert T Keenan, et al.
The Lancet. Diabetes & Endocrinology|May 23, 2021
Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre studyUte Spiekerkoetter, Maria L Couce, Anibh M Das, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ40 and Aβ42 following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteersAngelica Quartino, Gunilla Huledal, Erik Sparve, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 12, 2014
Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839Erik Sparve, Angelica L Quartino, Maria Lüttgen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Drug Testing and Analysis|October 19, 2017
A simple validated multi-analyte method for detecting drugs in oral fluid by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS)Yufang Zheng, Erik Sparve, Mats Bergström
Journal of Analytical Toxicology|March 5, 2020
Detection of Drugs in Oral Fluid Samples Using a Commercially Available Collection Device: Agreement with Urine Testing and Evaluation of A and B Samples Obtained from Employees at Different Workplace Settings with Uncontrolled Sampling ProceduresYufang Zheng, Erik Sparve, Stefan Sparring, et al.
Journal of Clinical Psychopharmacology|May 15, 2009
Acute clozapine intoxicationErik Sparve, Per Nordberg, Sune Forsberg, et al.
Basic & Clinical Pharmacology & Toxicology|August 19, 2009
Human exposure to triclosan via toothpaste does not change CYP3A4 activity or plasma concentrations of thyroid hormonesMats Allmyr, Georgios Panagiotidis, Erik Sparve, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2021
A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout FlaresKenneth G Saag, Puja P Khanna, Robert T Keenan, et al.
The Lancet. Diabetes & Endocrinology|May 23, 2021
Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre studyUte Spiekerkoetter, Maria L Couce, Anibh M Das, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ40 and Aβ42 following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteersAngelica Quartino, Gunilla Huledal, Erik Sparve, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 12, 2014
Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839Erik Sparve, Angelica L Quartino, Maria Lüttgen, et al.
Pageof 1